Description
Semaglutide is a GLP-1 receptor agonist used in clinically supervised weight-management and glycaemic-support programmes. The 0.5 mg pen is typically used as an initiation dose within structured protocols.
Details
Strength: 0.5 mg per pen
Route: Subcutaneous injection only
Storage: 2–8 °C refrigeration.












Reviews
There are no reviews yet.